Erratum: Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium (Stem Cells (2006) 24, (772-780) DOI: 10.1634/stemcells.2005-0212);Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium

Stem Cells

Volumn 24, Issue 3, 2006, Pages 772-780

  Leor, Jonathan ^a,b   Guetta, Esther ^a   Feinberg, Micha S ^a   Galski, Hanan ^a   Bar, Iris ^a   Holbova, Radka ^a   Miller, Liron ^a   Zarin, Parvin ^a   Castel, David ^a   Barbash, Israel M ^a   Nagler, Arnon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Aging; Heart; Myocardial infarction; Progenitor cells; Stem cells; Tissue therapy; Ventricular remodeling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD133 ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MYOFIBROBLAST; NEWBORN; NONHUMAN; RAT STRAIN; SCAR; STATISTICAL SIGNIFICANCE; STEM CELL; TISSUE REPAIR; UMBILICAL CORD BLOOD; X CHROMOSOME; Y CHROMOSOME; ERRATUM; RETRACTED ARTICLE; ANIMAL; CONVALESCENCE; CYTOLOGY; FETUS BLOOD; NUDE RAT; PATHOLOGY; RAT; STEM CELL TRANSPLANTATION;

ANIMALIA;

ANIMALS; ANTIGENS, CD; FETAL BLOOD; GLYCOPROTEINS; HUMANS; MYOCARDIAL INFARCTION; PEPTIDES; RATS; RATS, NUDE; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33744991561     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-erratum5     Document Type: Erratum

References (49)

1. Scheubel RJ, Zorn H, Silber RE et al. Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003;42:2073-2080.
2. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
3. Eizawa T, Ikeda U, Murakami Y et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 2004;90:685-686.
4. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
5. Heeschen C, Lehmann R, Honold J et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-1622.
6. Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106:2781-2786.
7. Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000;105:1527-1536.
8. Vendrame M, Cassady J, Newcomb J et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004;35:2390-2395.
9. Willing AE, Lixian J, Milliken M et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 2003;73:296-307.
10. Borlongan CV, Hadman M, Davis Sanberg C et al. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004;35:2385-2389.
11. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004;114:330-338.
12. Lewis ID, Verfaillie CM. Multi-lineage expansion potential of primitive hematopoietic progenitors: Superiority of umbilical cord blood compared to mobilized peripheral blood. Exp Hematol 2000;28:1087-1095.
13. Nieda M, Nicol A, Denning-Kendall P et al. Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol 1997;98:775-777.
14. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003;108:2070-2073.
15. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436.
16. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-376.
17. Murohara T. Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc Med 2001;11:303-307.
18. Etzion S, Battler A, Barbash IM et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001;33:1321-1330.
19. Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation 2003;108:863-868.
20. Schuster MD, Kocher AA, Seki T et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 2004;287:H525-H532.
21. Ando H, Kubin T, Schaper W et al. Cardiac microvascular endothelial cells express alpha-smooth muscle actin and show low NOS III activity. Am J Physiol Heart Circ Physiol 1999;276:H1755-H1768.
22. Jaroscak J, Goltry K, Smith A et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: Results of a phase 1 trial using the AastromReplicell System. Blood 2003;101:5061-5067.
23. Pesce M, Orlandi A, Iachininoto MG et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 2003;93:e51-e62.
24. Kogler G, Sensken S, Airey JA et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004;200:123-135.
25. Tsafrir A, Brautbar C, Nagler A et al. Alloreactivity of umbilical cord blood mononuclear cells: Specific hyporesponse to noninherited maternal antigens. Hum Immunol 2000;61:548-554.
26. Cohen Y, Nagler A. Hematopoietic stem-cell transplantation using umbilical-cord blood. Leuk Lymphoma 2003;44:1287-1299.
27. Henning RM, Abu-Ali H, Balis JU et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 2004;13:729-739.
28. Hirata Y, Sata M, Motomura N et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun 2005;327:609-614.
29. Ma N, Stamm C, Kaminski A et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 2005;66:45-54.
30. Balsam LB, Wagers AJ, Christensen JL et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-673.
31. + progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004;44:458-463.
32. Duffield JS, Park KM, Hsiao LL et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005;115:1743-1755.
33. Togel F, Hu Z, Weiss K et al. Amelioration of acute renal failure by stem cell therapy - paracrine secretion versus transdifferentiation into resident cells: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. J Am Soc Nephrol 2005;16:1153-1163.
34. Muller-Ehmsen J, Peterson KL, Kedes L et al. Rebuilding a damaged heart: Long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002;105:1720-1726.
35. Yao M, Dieterle T, Hale SL et al. Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol 2003;35:661-670.
36. Migrino RQ, Young JB, Ellis SG et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation 1997;96:116-121.
37. Zhang S, Wang D, Estrov Z et al. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 2004;110:3803-3807.
38. Kajstura J, Rota M, Whang B et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2004;96:127-137.
39. Reffelmann T, Dow JS, Dai W et al. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol 2003;35:607-613.
40. Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697-703.
41. + progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004;103:2942-2949.
42. Ma J, Ge J, Zhang S et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005;100:217-223.
43. Abbott JD, Huang Y, Liu D et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110:3300-3305.
44. Vandervelde S, van Luyn MJ, Tio RA et al. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005;39:363-376.
45. Aicher A, Brenner W, Zuhayra M et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-2139.
46. Devine SM, Cobbs C, Jennings M et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999-3001.
47. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-1910.
48. Hofmann M, Wollert KC, Meyer GP et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111:2198-2202.
49. Dai W, Hale SL, Martin BJ et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium. Short- and long-term effects. Circulation 2005;112:214-223.